Neurol. praxi. 2012;13(6):314-316

Aphasia and potential of screening evaluation using Mississippi Aphasia Screening Test - Czech version (MASTcz)

PhDr.Mgr.Milena Košťálová1,2
1 Neurologická klinika LF MU a FN Brno, Brno
2 CEITEC MU, Brno

Language disorders and their demonstrations such as aphasia, alexia and agraphia vary substantially. Their diagnostics, and especially

early stages of the disease after stroke, is complicated due to changes in symptomatology and coexisting cognitive disturbances.

Clinical examination of a patient with suspected language disorders focuses on detection of aphasia, alexia and agraphia. MASTcz is

a standardized screening test with a high sensitivity and specificity in detection of aphasia. It can to a certain extent quantify the severity

of language impairment, which helps an experienced aphasiologist to determine particular type of aphasia. The MASTcz test complies

with requirements on screening instruments and its limitations are discussed further in the text.

Keywords: aphasia, screening, MASTcz

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Košťálová M. Aphasia and potential of screening evaluation using Mississippi Aphasia Screening Test - Czech version (MASTcz). Neurol. praxi. 2012;13(6):314-316.
Download citation

References

  1. Bartoš A. Zjevná afázie není přítomna ani ve středním stadiu Alzheimerovy nemoci. Komentář k práci Košťálová, et al. Porovnání tíže afázie u demence a cévní mozkové příhody pomocí MASTcz a její vztah k tíží kognitivního deficitu. Cesk Slov Neurol N 2010; 70/106(3): 254-257.
  2. Cséfalvay Zs, Marková J, Košťálová M, Egryová M. Terapie afázie. Teorie a případové studie. Praha: Portál; 2007.
  3. Introduction to the Mississippi Aphasia Screening Test. Dostupné z: www.tbims.org./combi/mast/index.html.
  4. Kertesz A. Western Aphasia Battery. New York: Grune&Stratton; 1982.
  5. Kertesz A. Western Aphasia Battery revised. San Antonio: PsychCorp; 2007. Go to original source...
  6. Košťálová M, Bártková, E, Šajgalíková K, Dolenská A, Dušek L, Bednařík J. A standardization study of the Czech version of the Mississippi Aphasia Screening Test (MASTcz) in stroke patients and control subjects'. Brain Injury 2008; 22(10): 793-801. Go to original source... Go to PubMed...
  7. Košťálová M, Bednařík J. Screening afázie: MASTcz. Dostupné z URL: http://www.fnbrno.cz/nemocnice-bohunice/neurologicka-klinika/screening-afazie-mastcz/t3305.
  8. Košťálová M, Bednařík J, Skutilová S, Mitášová A, Bártková E, Šajgalíková K, Demovičová A, Dušek L. Porovnání tíže afázie u demence a cévní mozkové příhody pomocí MASTcz a její vztah k tíží kognitivního deficitu. Cesk Slov Neurol N 2010; 73/106(3): 246-252.
  9. Nakase-Thompson R, Manning E, Sherer M, Yablon SA, Vickery C, Harris C, et al. Bedside screen of language disturbance aminy acute care admissions: Initial psychometrice of the Mississippi Aphasia Screening Test. Archives of Clinical Neuropsychology 2002; 17: 848.
  10. Nakase-Thompson R, Manning E, Sherer M, Yablon SA, Gontkovsky SLT, Vickery C. Brief assessment of severe language impairments: Initial validation of the Mississippi aphasia screening test. Brain Injury 2005; 19: 685-691. Go to original source... Go to PubMed...
  11. Patterson JP, Chapey R. Assesment of Language Disorders in Adults. In: Chapey R (ed). Language Intervention Strategies in Aphasia and Related Neurogenic Communication Disorders. 5th ed.: Lippincott Williams & Wilkins 2008: 64-73.
  12. Preiss M, Kučerová H, a kol. Neuropsychologie v psychiatrii. Praha: Grada Publishing, a.s.; 2006.
  13. Romero M, Sánchez A, Marín C, Navarro MD, Ferri J, Noé E. Clinical usefulness of the Spanish version of the Mississippi Aphasia Screening Test (MASTsp): validation in stroke patients. Valencia: Neurología Elsevier Espana. 2011. Go to original source...
  14. Salter K, Jutai J, Foley N, Hellings CH, Tesel R. Identification of aphasia post stroke: A review of screening assessment tools. Brain Injury, 2006; 20(6): 559-558. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.